2017. Jul

Effectiveness of levetiracetam in an acetazolamide-unresponsive patient with episodic ataxia type 2 by a novel CACNA1A nonsense mutation.

Eur J Neurol. 2017

Lee H, Jang DH, Jang JH, Kim T.

Green Cross Genome Corporation I  Representative: KI CHANG SEOK   I   Business Registration No. 142-81-61687

107, Ihyeon-ro 30beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, 16924, Korea

Email. info.gcgenome@gccorp.com  I  Tel. +82 31-280-9939   I    Fax. +82 31-260-9087

©2020 by GC Genome.